Why Does a Granulated API Suppress Capping in High-Dose Swine Tablets?

For Jinhuang Lianban Granules Veterinary Grade API in swine oral solid tablet manufacture, the granulated form is dry-delumped through a conical mill fitted with a 0.5 mm screen before blending because retained agglomerates above 850 µm cause radial segregation in the feed frame and cap formation on rotary presses. Manufacturer batch records for high-dose herbal extract tablets show that direct compression of spray-dried powder fails when API content exceeds 30% w/w due to elastic recovery after ejection; granulation to a bulk density of 0.55–0.70 g/mL and Carr Index below 25% removes this failure mode. The formulation addition ratio for tablet cores is 15–35% w/w Jinhuang Lianban Granules Veterinary Grade API, adjusted according to marker assay and target dose. Industry compliance is anchored to USP <905> for content uniformity, USP <711> or Ph. Eur. 2.9.3 for dissolution, and 21 CFR 211.165 batch release testing. The downstream manufacturing process blends API and microcrystalline cellulose in a bin blender at 10–15 rpm for 15–20 min; crospovidone is then added as disintegrant, and magnesium stearate is screened separately and introduced last at 0.5–1.0% w/w to avoid over-lubrication. Compression is performed on a 16-station rotary tablet press with 60–90 N hardness and friability below 1.0%. Finished product types include uncoated tablets for oral administration to swine and film-coated tablets where protection from salivary degradation is required. Pre-drying at 45°C for 2 h is required when relative humidity exceeds 60%; hypromellose film coating should be avoided if granule moisture is below 2.0% because brittle film adhesion occurs.

Filling hygroscopic granules into hard gelatin capsules at 45% RH requires a clear separation between sorption-derived adhesive force and electrostatic charge accumulation, because both defects produce shell splitting at high speed. The capsule blend addition ratio for Jinhuang Lianban Granules Veterinary Grade API is restricted to 20–40% w/w; above this range the hygroscopic extract fraction increases the equilibrium moisture content of the filled shell, and below this range the dose unit may become too large for size 0 capsules. Industry compliance for this non-sterile oral product is governed by Ph. Eur. 2.9.1 disintegration and USP <711> dissolution, with microbiological release limits according to USP <1111> and 21 CFR 211.166 stability protocols. The downstream process requires delumped API to be dry-blended with microcrystalline cellulose and colloidal silicon dioxide at 45% RH in a bin blender, followed by magnesium stearate lubrication; filling is performed on an intermittent-motion dosator capsule machine equipped with 5 mm tamping pins, because dosator machines handle the granule size fraction between 125 µm and 710 µm better than auger systems. Terminal product types include hard gelatin capsules and hydroxypropyl methylcellulose capsules for oral administration to swine and calves. If the granule moisture exceeds 6%, the fill is rejected due to shell softening; if moisture falls below 2%, static adhesion to the dosator causes weight variation above 4% RSD.

Injectable Solutions Require a Two-Barrier Depyrogenation Strategy

Granulated API cannot be assumed pyrogen-free even when compendial Water for Injection is used, because endotoxin can be introduced by the extract matrix and by processing equipment. The formulation addition ratio for injectable solutions is based on active-equivalent concentration rather than simple dry mass: Jinhuang Lianban Granules Veterinary Grade API is dispersed at 50–100 g/L in Water for Injection, corresponding to 5–10% w/v, and the exact mass is adjusted after marker assay because the granular form retains 4–8% moisture and a variable non-soluble residue. Compliance is anchored to USP <71> sterility tests, USP <85> bacterial endotoxins, USP <788> particulate matter in injections, Ph. Eur. 2.6.1, Ph. Eur. 2.6.14, 21 CFR 211.42 facility requirements, ISO 14644-1:2015 cleanroom classification, and VICH GL18 for residual solvent control. The downstream process begins with cold dispersion at 10–20°C in a high-shear mixer at 800–1,200 rpm to prevent clumping; pH is adjusted to 6.5–7.5 with 0.1 M sodium hydroxide or tromethamine, and tonicity is adjusted with sodium chloride to a target of 280–320 mOsm/kg. The solution is filtered sequentially through 0.45 µm and 0.22 µm PVDF membranes; the 0.22 µm membrane is a sterilizing filter but is not a depyrogenation step, so depyrogenation of equipment by dry heat at 250°C for 30 min remains mandatory. Published data for this specific configuration is limited; therefore the terminal sterilization cycle at 121°C for 15 min must be confirmed by a worst-case bioburden study according to 21 CFR 211.113(b). Finished product types include sterile injectable solution in 50 mL or 100 mL Type II amber vials for intramuscular or subcutaneous administration to swine and cattle; multi-dose containers require preservative efficacy testing under USP <51> and a maximum 2% v/v benzyl alcohol if justified. If the extract fraction is heat-labile, terminal sterilization is replaced by aseptic filtration, but this change requires an isolator environment meeting ISO 14644-1:2015 class A within class B background.

Water hardness above 180 mg/L CaCO₃ alters the dispersion rate of a granulated veterinary API in nipple-drinker systems, and this single variable determines whether a soluble powder can be used in field poultry installations. The formulation addition ratio in water-dispersible granules is set at 40–70% w/w Jinhuang Lianban Granules Veterinary Grade API because higher loadings leave insufficient carrier mass to control wetting, while lower loadings force a larger dose of excipient into the drinking water line. Industry compliance for this non-sterile oral powder is based on 21 CFR 211.110 in-process testing, USP <1111> microbial limits for non-sterile products, and pharmacopoeial specifications for loss on drying according to USP <731>. The downstream manufacturing process uses fluid-bed spray granulation rather than dry mixing because the extract surface must be coated with a water-soluble film of lactose and sodium citrate to prevent hydrophobic agglomeration; inlet air temperature is held at 45–55°C, product temperature at 30–35°C, and spray rate at 30–50 g/min for a 10 kg bowl. After drying to a moisture content below 4%, the granules are sieved through 850 µm and 150 µm screens to remove overs and fines. Dispersion time is controlled to 5 min or less in water at 10°C and pH 7.5, with no more than 0.5% residue on a 150 µm sieve. Finished product types include water-soluble powder packed in sealed aluminum foil sachets, water-dispersible granules for stock suspension preparation, and preweighed drench powders for oral administration to poultry and weaned pigs. The granulated API should not be blended with citric acid monohydrate without compatibility testing, because acid-catalyzed degradation of the extract marker compounds accelerates at storage temperatures above 30°C.

If the Granular API Reaches the Mixer at Moisture Above 12%, Feed Premix Carryover Fails Homogeneity Limits

Medicated feed premix production begins with carrier selection, not active blending. The addition ratio for Jinhuang Lianban Granules Veterinary Grade API is calculated backward from the prescribed finished feed dose; for a 1 kg premix added to 1,000 kg complete feed at 200 g/ton active equivalent, the API fraction in the premix is 20% w/w. Lower premix use rates, such as 0.5 kg/ton, raise the required API fraction to 40% w/w and increase segregation risk. Compliance is derived from 21 CFR 558.6 VFD drug regulations, EU 2019/6 Chapter V on medicated feed, ISO 22000:2018 feed safety management, and GMP+ BA2 feed additive assurance where applicable. The downstream process uses a ribbon mixer with a working volume of 300 L; the carrier, typically ground corncob or dried corn gluten, is preloaded, and the granular API is diluted in three steps at 3:1 carrier-to-active ratios before final mixing at 20 rpm for 15–20 min. Homogeneity is confirmed by sampling 10 locations and requiring a coefficient of variation below 5% for the marker compound; carryover is validated with a flush material of 2% salt in ground corn and an acceptance limit below 1% carryover into the next batch. The granular API requires moisture below 12% before mixing; above this threshold, it forms adhesive bridge deposits on ribbon mixer blades and increases the coefficient of variation above 5%. Finished product types include medicated feed premix, Type A medicated article for further dilution, and top-dress powder for use on farrowing house creep feed. This route is not compatible with pelleted feed extruded above 80°C unless thermostability of the extract marker compound has been confirmed.

Oral Solutions and Drench Formulations Under High-Tannin Extract Load

Oral solution preparation from a granular API requires a different dissolution sequence than dry mixing: the granules are first wetted with glycerol at a ratio of 1:2 w/w before the aqueous phase is added, otherwise the extract particles form a gelled shell that reduces yield. The formulation addition ratio is 20–60 g/L Jinhuang Lianban Granules Veterinary Grade API, equivalent to 2–6% w/v, with the upper limit controlled by viscosity and the lower limit controlled by dose accuracy in drench guns. Compliance is anchored to USP <51> antimicrobial effectiveness testing for preserved oral solutions, Ph. Eur. 2.2.3 for potentiometric pH, USP <785> for osmolality of oral solutions, and 21 CFR 211.100 process validation. The downstream process uses a jacketed stainless mixing vessel at 40°C; purified water is charged first, sodium benzoate is dissolved at 0.1–0.2% w/v, and the pre-wetted API paste is added under a high-shear mixer at 500–800 rpm for 20 min. The solution is passed through a 10 µm inline filter before filling into high-density polyethylene bottles; settling after 24 h must be below 0.2% by volume, otherwise a suspending system with xanthan gum at 0.15% w/v is introduced. pH is adjusted to 4.0–5.5 with citric acid or sodium citrate, because alkaline pH accelerates oxidation of phenolic markers and reduces preservative efficacy. Finished product types include oral drench solution for administration to swine and cattle, oral solution for poultry metering pumps, and concentrated stock solution for dilution to a final drinking-water concentration. The granular API should not be combined with cationic preservatives such as benzalkonium chloride without compatibility testing, because complexation with anionic extract components can form visible precipitates.